University of Wisconsin Pain & Policy Studies Group World Health Organization Collaborating Center for Pain Policy and Palliative Care Action Plan for:

Slides:



Advertisements
Similar presentations
Culturally and Linguistically Appropriate Services And Clinical Trials (EDICTs CLAS-ACT) Armin D Weinberg Baylor College of Medicine.
Advertisements

Common/shared responsibilities between jobs.
World Health Organization
Iowa Prescription Drug Corporation Iowa Prescription Drug Corporation State Historical Society November 8, 2013 Iowa Collaborative Safety Net Provider.
Introduction to Treat the Pain. The problem of unrelieved pain Globally, 7.3 million people die of cancer or HIV each year in moderate or severe pain.
1 Potential & Actual Opioid Diversion in Vietnam, Methods of Preventing Diversion, and Barriers to “Balance” Eric Krakauer, MD, PhD Harvard Medical School.
PSK Annual Conference 2008 Palliative care medicine: A balanced approach to opioid availability and safe use in Kenya Presenter: Dr. Bilha Kiama-Murage.
Matching Interventions to Barriers in Pain Management Ruth Cornish Program Manager.
RENI PRIMA GUSTY, SK.p,M.Kes
Perspectives of Former International Pain Policy Fellows International Pain Policy Fellowship Training Program Madison, Wisconsin, USA 6 August 2012 Bishnu.
Role of Pharmacist in Malaria Control
University of Wisconsin Pain & Policy Studies Group World Health Organization Collaborating Center for Pain Policy and Palliative Care Cohort III International.
Situation analysis in Kyrgyzstan Making Opioids Available in Eastern Europe and Central Asia March 5-6, 2013 Vienna.
Pharmacy Services.
Association of Pharmaceutical Companies Representatives in Georgia APCRG, WASHINGTON DC, February
HIV/AIDS prevention and care among injecting drug users and in prison settings in Estonia, Latvia and Lithuania Signe ROTBERGA UNODC, Baltic States 5 November.
March года Barcelona, Spain Tajikistan country presentation.
DON’T FORGET THE ‘E’ IN “MORPHINE” International Pain Policy Fellowship: Advocacy & Communications.
Primary Care Workforce Summit November 29, 2012 Country Springs Hotel, Waukesha Primary Care Workforce Summit Pharmacy Perspective Kate Hartkopf, PharmD.
1. 2 Melinda Campopiano, MD Medical Officer Center for Substance Abuse Treatment Substance Abuse and Mental Health Services Administration U.S. Department.
Ukraine:Palliative care development Brasov, Romania October 25-28, 2011 Украина: Развитие паллиативной помощи Брашов, Румыния октября 2011 года.
KENTUCKY YOUTH FIRST Grant Period August July
Country Report for: UKRAINE Natallia Datsiuk, MPH Bogomolets National Medical University Ukraine, Kyiv.
Understanding and Using INCB Opioid Consumption Statistics: Including Morphine Equivalence 8 August 2012 Martha Maurer, MSW, MPH, PhD Pain & Policy Studies.
For Pain or Not for Pain: Methadone Madness
Current System of Drug Control In Georgia Prof. D. Kordzaia – Georgian National Association for Palliative Care VIENNA - March 5-6, 2013 “Making Oral Opioids.
“Improving opioid availability through advocacy” Experience from Serbia Snežana Bošnjak International Pain Policy Fellow ( ) Institute for Oncology.
Ministry of Health of the Republic of Armenia Feb 2013.
WHO Access to Controlled Medications Programme & Ensuring balance in national policies on controlled substances Barbara Milani, Technical Officer Department.
Overviews of the Drug Distribution System & Barriers to Opioid Availability Dr. Bishnu Dutta Paudel International Pain Policy Fellowship Training Program.
University of Wisconsin Pain & Policy Studies Group World Health Organization Collaborating Center for Pain Policy and Palliative Care Country Report for:
Progress to date and Plans for Year 5 Overcoming HIV/AIDS epidemic in Ukraine Programme supported by the Global Fund 11 th Stakeholders’ meeting 22 nd.
Medicines and Service Availability and Accessibility in Cancer Care in Georgia 28 th August 2012 Tbilisi Tamari Rukhadze MD. PhD. Oncologist, International.
ACCESS TO MEDICINES - POLICY AND ISSUES
Institut Català d’Oncologia ICO DiR. The ‘Qualy’ End of Life Care Observatory - WHO Collaborating Centre for Public Health Palliative Care Programmes Central.
San Francisco County OBOT Pilot: Pharmacy Aspects Sharon Kotabe, PharmD Associate Administrator for Pharmaceutical Services Associate Clinical Professor.
ABSTRACT Title: Developing National Formularies Based on the WHO Model Formulary Authors: Tisocki K 3, Laing RL 1, Hogerzeil H 1, Mehta DK 2, Ryan RSM.
Policy track summary ICIUM 2011 – 18 Nov Policy track topics 1.The pharmaceutical policy process 2.Quality and safety of medicines in LMIC 3.Policy.
Methods to Evaluate and Improve National Policy: Focus on 2011 WHO Guidelines and PPSG Global Policy Evaluation Aaron M. Gilson, MS, MSSW, PhD Research.
“” “Balance” Jim Cleary, MD Associate Professor of Medicine Director, Palliative Care Medicine, UW Hospital & Clinics Director, WHO Collaborating Center.
Social Pharmacy Lecture no. 6 Rational use of drugs Dr. Padma GM Rao
Single Convention on Narcotic Drugs Establishes a regulatory system for narcotic drugs government authorization is required for participation in the trade.
Texas State Board of Medical Examiners Bruce A. Levy, M.D., J.D.
PATIENT-CENTERED OUTCOMES RESEARCH INSTITUTE PCORI Board of Governors Meeting Washington, DC September 24, 2012 Anne Beal, MD, MPH, Chief Operating Officer.
Global Challenges in Cancer Pain S. Lawrence Librach MD,CCFP,FCFP Professor, Department of Family & Community Medicine Sun Life Financial Chair & Director,
Ensuring Availability and Preventing Diversion International Pain Policy Fellowship August 7, 2012 David E. Joranson University of Wisconsin Pain & Policy.
University of Wisconsin Pain & Policy Studies Group World Health Organization Collaborating Center for Pain Policy and Palliative Care Cohort III International.
“USAPI-PHARMACY ASSOCIATION - RESPONSE TO NCD ROADMAP” Evelyn Ahhing-Faaiuaso RPH PHARMD Pihoa 51 st 1-18 nov 2011 Evelyn Ahhing-Faaiuaso RPH PHARMD Pihoa.
"Perspectives of former International Pain Policy Fellows" Prof. Snežana Bošnjak, MD, PhD Institute for Oncology and Radiology of Serbia (IORS) Belgrade,
University of Wisconsin Pain & Policy Studies Group World Health Organization Collaborating Center for Pain Policy and Palliative Care Cohort III International.
Using drug use evaluation (DUE) to optimise analgesic prescribing in emergency departments (EDs) Karen Kaye, Susie Welch. NSW Therapeutic Advisory Group*
University of Wisconsin Pain & Policy Studies Group World Health Organization Collaborating Center for Pain Policy and Palliative Care Action Plan for:
Dr Ihor Perehinets MD, MPH National Technical Officer WHO CO in Ukraine Pharmacovigilance (PV) in HIV treatment in Ukraine: Situation Analysis Dar es Salaam.
National Public Health Performance Standards Local Assessment Instrument Essential Service:6 Enforce Laws and Regulations that Protect Health and Ensure.
Introduction to pain Disclaimer: This presentation contains information on the general principles of pain management. This presentation cannot account.
Preventing drug diversion: Principles and concepts International Pain Policy Fellowship August 7, 2012 David E. Joranson Distinguished Scientist, Founder.
Pethidine prescribing in the ED… Let’s be rational! Kaye KI, Maxwell DJ, Graudins L, on behalf of the the NSW Therapeutic Assessment Group (NSW TAG) Drug.
Quality Care Standards Authors: Frokjaer B, Grant RL Problem Statement: All practicing pharmacists are obliged to ensure that the service they provide.
University of Wisconsin Pain & Policy Studies Group World Health Organization Collaborating Center for Pain Policy and Palliative Care Cohort III International.
Strategic Objective 4 To promote the exchange of experiences and regulatory knowledge between NRAs inside and outside PANDRH“ Lessons learned from international.
What is Managed Care Pharmacy? Developed by AMCP Membership Committee
Prepared by: Imon Rahman Lecturer Department of Pharmacy BRAC University.
Community Pharmacy: Sharing Our Vision
San Francisco County OBOT Pilot: Pharmacy Aspects
MDHHS Response to the Opioid Crisis
Federal Regulations requirements for opioid prescription course
Indispensable, adequately provided and not unduly restricted
Impact of Policy and Regulatory Responses to the Opioid Epidemic on the Care of People with Serious Illness Hemi Tewarson, Director, Health Division National.
Background Cancers are among the leading causes of morbidity and mortality worldwide, responsible for 18.1 million new cases and 9.6 million deaths in.
Situation analysis in Kyrgyzstan
Presentation transcript:

University of Wisconsin Pain & Policy Studies Group World Health Organization Collaborating Center for Pain Policy and Palliative Care Action Plan for: UKRAINE Prepared by: Nataliia Datsiuk Andrii Shapovalov Asra Husain Karen Ryan 10 August 2012

University of Wisconsin Pain & Policy Studies Group World Health Organization Collaborating Center for Pain Policy and Palliative Care 1: State the 3-5 problems that lead to inadequate patient access to opioid analgesics – Be as specific as you can Problem 1: Problem 2: Problem 3: Problem 4: Problem 5: Domain common society opinion that narcotic drugs is an absolute evil Strict regulation on prescribing opioids Absence of oral morphine Lack of recognition among specialists (top managers, physicians, pharmacists) that opioids are essential for moderate and severe pain relief Inaccessibility of opioids in rural areas

University of Wisconsin Pain & Policy Studies Group World Health Organization Collaborating Center for Pain Policy and Palliative Care 1.Importers are not interested in importation of morphine due to lack of profit and bureaucracy of procedure of market authorization 2.Domestic manufacturer doesn’t want to produce morphine in tab (lack of profit) 3.No provision in the national medicines policy that oral morphine is absolutely necessary - Absence of forms and dosage in List of essential medicine -Absence of special address in National Cancer Program -Misinterpretation of WHO ladder in clinical guidelines PROBLEM 1 Absence of oral morphine

University of Wisconsin Pain & Policy Studies Group World Health Organization Collaborating Center for Pain Policy and Palliative Care 1.Manufacture or/and import the oral morphine 2.Provide the provision in the national drug policy that oral morphine is absolutely necessary B: State the objective(s) that would address the problem. Which objectives are the top priorities? (What?)

University of Wisconsin Pain & Policy Studies Group World Health Organization Collaborating Center for Pain Policy and Palliative Care C: What action steps are needed to achieve the objectives? (How?) 1.Participate in negotiations with potential importers and domestic manufacture initiated by Ukrainian League of Hospice and Palliative Care (League) and IRF 2.Find other potential importers of morphine tablets 3.Identify the main problems of process of market authorization of morphine tablets 4.Make proposition about: Essential List of Medicines by adding dosages and forms; special address in National Cancer Program to opioid availability and promote WHO step ladder; examine the WHO method proposed in National guidelines Morphine production: MoH, Domestic manufacture, importers, IRF, League Market authorization: Pharmaceutical Center of MoH, State Service of Quality Control National drug policy: MoH, League, AIDS Alliance, Health rights organization D: List those who have the authority and/or responsibility to take the necessary action; and with whom they should collaborate. (Who?)

University of Wisconsin Pain & Policy Studies Group World Health Organization Collaborating Center for Pain Policy and Palliative Care E: Timeline for completion of action steps. (When?) Experts support in: - import, manufacture, authorization of oral morphine -WHO ladder provision in national guidelines -Opioids availability in national programs (cancer, AIDS) F: What assistance (technical, financial) will be needed to achieve each objective under part “B”? (How much?) StepTime To participate in starting negotiate with potential importers and domestic manufacture August - ….. Identify the main problems of process of market authorization of tab.morphine September - November Making proposition about changes to national medicines policy 2012

University of Wisconsin Pain & Policy Studies Group World Health Organization Collaborating Center for Pain Policy and Palliative Care 1.Oral morphine available 2.Oral morphine in National List of Essential medicine 3.WHO ladder endorsed in right way 4. Address opioid availability in national programs G: Expected outputs, and how measured

University of Wisconsin Pain & Policy Studies Group World Health Organization Collaborating Center for Pain Policy and Palliative Care Limit the dose prescribing Heavy prescribing procedure PROBLEM 2 Strict regulation on prescribing opioids

University of Wisconsin Pain & Policy Studies Group World Health Organization Collaborating Center for Pain Policy and Palliative Care 1.Physician must prescribe morphine in dose that is needed for patient pain relief 2.Morphine prescription for cancer patient is decision of one physician 3.No additional stamps and signs 4.More days for prescription and for valid prescriptions B: State the objective(s) that would address the problem. Which objectives are the top priorities? (What?)

University of Wisconsin Pain & Policy Studies Group World Health Organization Collaborating Center for Pain Policy and Palliative Care C: What action steps are needed to achieve the objectives? (How?) 1.Define what is the main guidelines for physician about dosage prescribing and promote physician with this information 2.Identify and revise all prescription barriers 3.Learn other country experience and create appropriate model for Ukraine of prescribing morphine(certification of physicians, duration of prescription ?) 1.WHO, NICE, Association of oncologists, Institute of Palliative and Hospice Care, Pharmacological Center of MoH National Association, Education Institution, Cancer Center 3. State Service on Drug Control, MoH, Ukrainian League of Palliative Care D: List those who have the authority and/or responsibility to take the necessary action; and with whom they should collaborate. (Who?)

University of Wisconsin Pain & Policy Studies Group World Health Organization Collaborating Center for Pain Policy and Palliative Care E: Timeline for completion of action steps. (When?) PPSG, Fellows from other countries, State Service on Drug Control F: What assistance (technical, financial) will be needed to achieve each objective under part “B”? (How much?) StepTime Define what is the main guidelines for physician about dosage prescribing and promote physician with this information September- October Identify and revise prescription barriers 2012 Learn other country experience and create appropriate model for Ukraine of prescribing morphine(certification of physicians, duration of prescription ?) 2012

University of Wisconsin Pain & Policy Studies Group World Health Organization Collaborating Center for Pain Policy and Palliative Care 1.No prescription dose limit of morphine for pain relief 2.Simplification prescribing procedure of opioids for pain relief 3.Long duration of prescription and validity of it G: Expected outputs, and how measured

University of Wisconsin Pain & Policy Studies Group World Health Organization Collaborating Center for Pain Policy and Palliative Care Lack of pharmacy/health care sites which has license for handling of opioids because of vary high costs of ensuring requirements for getting the license (special equipped room, alarm system) and low profit of morphine PROBLEM 3 Inaccessibility of opioids in rural areas

University of Wisconsin Pain & Policy Studies Group World Health Organization Collaborating Center for Pain Policy and Palliative Care 1.To create a network of pharmacies or heath care sites which has license for handling opioids B: State the objective(s) that would address the problem. Which objectives are the top priorities? (What?)

University of Wisconsin Pain & Policy Studies Group World Health Organization Collaborating Center for Pain Policy and Palliative Care C: What action steps are needed to achieve the objectives? (How?) 1.Identify and revise all barriers of opioids inaccessibility in rural areas 2.Learn the system of methadone transportation 3.Explore how to provide incentives for pharmacy to stock and dispense morphine 4.Learn other country experience about distribution system and create appropriate model for Ukraine MoH, State Service on Drug Control, National Pharmaceutical Association, Ukrainian League of Palliative Care D: List those who have the authority and/or responsibility to take the necessary action; and with whom they should collaborate. (Who?)

University of Wisconsin Pain & Policy Studies Group World Health Organization Collaborating Center for Pain Policy and Palliative Care E: Timeline for completion of action steps. (When?) PPSG, Fellows from other countries, State Service on Drug Control F: What assistance (technical, financial) will be needed to achieve each objective under part “B”? (How much?) StepTime Identify and revise all barriers of opioids inaccessibility in rural areas Learn the system of methadone transportationMarch 2013 Learn other country experience about distribution system and create appropriate model for Ukraine

University of Wisconsin Pain & Policy Studies Group World Health Organization Collaborating Center for Pain Policy and Palliative Care 1.Increase numbers of pharmacies in rural areas which have licenses to handling of opioids 2.Increase availability of opioids for rural population G: Expected outputs, and how measured

University of Wisconsin Pain & Policy Studies Group World Health Organization Collaborating Center for Pain Policy and Palliative Care PROBLEM 4 Lack of recognition among specialists that opioids are essential for moderate and severe pain relief

University of Wisconsin Pain & Policy Studies Group World Health Organization Collaborating Center for Pain Policy and Palliative Care 1.Aware top/state health care managers (MoH), pharmaceutical and physicians community about the problem of opioids availability 2.Use WHO for pain relief 3.Include the topics of palliative care, availability of opioids, principle of “balance” in drug control in education curriculum of medical and pharmaceutical department B: State the objective(s) that would address the problem. Which objectives are the top priorities? (What?)

University of Wisconsin Pain & Policy Studies Group World Health Organization Collaborating Center for Pain Policy and Palliative Care C: What action steps are needed to achieve the objectives? (How?) 1.Promote the MoH with information about availability of opioids, comparing data of consumption in Ukraine and other countries, experts opinion 2.Present the results of research of opioid availability at state conference, meetings (National Palliative Congress, National Pharmaceutical Conference, Congress of Oncologists et al.) 3.Promote the WHO method 4.Revise medical and pharmaceutical curriculum, give the proposition to include topics and write methodological base State Service on Drug Control, Ukrainian League of Palliative Care, Institute of Palliative and Hospice Care, National medical University, National Pharmaceutical Academy, IRF (Needs assessment in palliative care – grant from OSF/IRF to Caritas Ukraine), Ukraine Association of Study Pain et al. D: List those who have the authority and/or responsibility to take the necessary action; and with whom they should collaborate. (Who?)

University of Wisconsin Pain & Policy Studies Group World Health Organization Collaborating Center for Pain Policy and Palliative Care E: Timeline for completion of action steps. (When?) 1.Technical support: State Service on Drug Control, PPSG, WHO 2,3 Financial support 4. Technical and financial support F: What assistance (technical, financial) will be needed to achieve each objective under part “B”? (How much?) StepTime Promote the MoH with information about role and availability of opioids, comparing data of consumption in Ukraine and other countries, experts opinion 2012 Present the results of research of opioid availability at state conference, meetings Promote the WHO method Revise medical and pharmaceutical curriculum, give the proposition to include topics and write methodological base

University of Wisconsin Pain & Policy Studies Group World Health Organization Collaborating Center for Pain Policy and Palliative Care 1.Increase the awareness of professional society of availability of opioids 2.Educational curriculum of pharmaceutical and medical department include the topics of palliative care, availability of opioids, principle of “balance” in drug control in education curriculum of medical and pharmaceutical department G: Expected outputs, and how measured

University of Wisconsin Pain & Policy Studies Group World Health Organization Collaborating Center for Pain Policy and Palliative Care PROBLEM 5 Domain common society opinion that narcotic drugs is an absolute evil Absence of balance approach in policy of drug control Misinterpretation of “addiction”, “dependence syndrom”

University of Wisconsin Pain & Policy Studies Group World Health Organization Collaborating Center for Pain Policy and Palliative Care Approve draft “National Drug Strategy of Ukraine” created by State Service on Drug Control which ensure the concept of “balance” Include in regulatory acts the approach of “balance” Include in all activity concern prevention of drug dependence the statement that opioids is indispensable for pain relief Revise regulatory acts concern terminology (“dependence syndrome”) B: State the objective(s) that would address the problem. Which objectives are the top priorities? (What?)

University of Wisconsin Pain & Policy Studies Group World Health Organization Collaborating Center for Pain Policy and Palliative Care C: What action steps are needed to achieve the objectives? (How?) 1.Make proposition about including in regulatory acts the principle of “balance” 2.Formulate and include in all activities concern prevention of drug dependence the statement of the role of opioids in medicine (preventive drug and alcohol program of MoH targed at pupils, parents and staff at school) 3.Identify negative and wrong language concern “dependence syndrome” and make proposition how to change it State Service on Drug Control, MoH D: List those who have the authority and/or responsibility to take the necessary action; and with whom they should collaborate. (Who?)

University of Wisconsin Pain & Policy Studies Group World Health Organization Collaborating Center for Pain Policy and Palliative Care E: Timeline for completion of action steps. (When?) 1, 3 Technical support: State Service on Drug Control, PPSG, WHO, UNODC (regional office in Ukraine) 2.Financial support F: What assistance (technical, financial) will be needed to achieve each objective under part “B”? (How much?) StepTime Make proposition about including in regulatory acts the principle of “balance” March 2013 Formulate and include in all activities concern prevention of drug dependence the statement of the role of opioids in medicine Identify negative and wrong language concern “dependence syndrome” and make proposition how to change it 2012

University of Wisconsin Pain & Policy Studies Group World Health Organization Collaborating Center for Pain Policy and Palliative Care 1.Concept of “balance” in regulatory acts 2.Programs of prevention drug and alcohol abuse target to pupils, school staff and parents include the statement that opioids are indispensable 3.Regulatory acts does not include wrong terminology G: Expected outputs, and how measured